Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - acetylcysteine 200 mg/ml - concentrate for injection - 2 g/10ml - active: acetylcysteine 200 mg/ml excipient: disodium edetate dihydrate sodium hydroxide 5 m: 14.557 - 43.671 mg/ml sodium hydroxide water for injection - n-acetylcysteine is indicated for the treatment of paracetamol overdose in patients: - who present within 8 hours after an acute overdose of immediate-release paracetamol, with a serum paracetamol level on or over the nomogram line, or - who present more than 8 hours after an acute overdose of immediate-release paracetamol, or - who have ingested >= 200 milligrams/kg or >= 10 g (whichever is less) of modified-release paracetamol, or - who have ingested < 200 milligrams/kg and < 10 g of modified-release paracetamol, with serum paracetamol level over the nomogram line, or - who have ingested >= 200 milligrams/kg or >=10 g (whichever is less) of paracetamol over a single 24 hour period, and have an alt >=50 u/l or serum paracetamol concentration >=20 milligrams/l (132 micromol/l), or - who have ingested >=300 milligrams/kg or >=12 g (whichever is less) of paracetamol over a single 48 hour period, and have an alt >=50 u/l or serum paracetamol concentration >=20 milligrams/l (132 micromol/l), or - who have ingested the equivalent or more of a daily therapeutic dose of paracetamol per day for more than 48 hours and also have abdominal pain or nausea or vomiting, and have an alt >=50 u/l or serum paracetamol concentration >=20 milligrams/l (132 micromol/l), or - where there is any doubt over the time of an acute overdose, irrespective of serum paracetamol level, or - where serum paracetamol concentration is >=150 milligrams/l 4 hours post-ingestion in children less than 6 years of age.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

max health limited - acetylcysteine 20%{relative} - concentrate for infusion - 20% w/v - active: acetylcysteine 20%{relative} excipient: disodium edetate sodium hydroxide - n-acetylcysteine is indicated for the treatment of paracetamol overdose in patients: · who present within 15 hours after an acute overdose with a plasma paracetamol level on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · who have taken more than 200mg/kg or 10g (whichever is less) of sustained release paracetamol or have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · who have taken an acute overdose of paracetamol with opiates or medicines with anticholinergic effects and have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · where there is any doubt over the time of an acute overdose, irrespective of plasma paracetamol level or · who present more than 15 hours after an overdose with abnormal liver biochemistry (inr >1.3 and/or alt>150) or fulminant hepatic failure or · who have taken a staggered overdose irrespective of plasma paracetamol level. staggered is defined as an overdose of 200mg/kg or 10g (whichever is less) over a single 24 hour period or 150mg/kg of 6g (whichever is less) per 24 hour period for at least 48 hours.

Inde - anglais - Central Drugs Standard Control Organization

micro lab. - beta carotene,vit.e,vit.c,zinc oxide,selenium,chromium,n-acetylcystein - cap - 10mg,15mg,75mg,20mg,100mcg,150mcg,200mg - 10

Inde - anglais - Central Drugs Standard Control Organization

entod ph. - carboxymethyl cellulose,n-acetylcarnosine,glycerin,boric acid - eye dps - 3,10,10,3;mg - 10ml

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - paracetamol; phenylephrine hydrochloride - oral tablet - 500mg ; 6.1mg

Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - paracetamol; phenylephrine hydrochloride - oral tablet - 500mg ; 6.1mg

Israël - anglais - Ministry of Health

medison pharma ltd - amifampridine - tablets - amifampridine 10 mg - amifampridine - symptomatic treatment of lambert-eaton myasthenic syndrome (lems) in adults

Inde - anglais - Central Drugs Standard Control Organization

ttk hc. - chromium picolinate,altacalcidol,n-acetylcysteine - tab - 500mcg,0.5mcg,600mg - 3*10

Inde - anglais - Central Drugs Standard Control Organization

celon - acetylcysteine - tab - 600mg(n-acetylcysteine) - 10

Inde - anglais - Central Drugs Standard Control Organization

klm lab. - biotin - f. - with vit.b5,n-acetylcysteine and minerals - 10*10